People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Discover the hidden inflammation in psoriasis patients' intestines, its link to leaky gut, and the increased risk of Crohn's ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other ...

Soligenix, a late-stage biopharmaceutical company, is advancing a novel therapeutic approach for treating mild-to-moderate psoriasis through its innovative SGX302 treatment. The therapy targets the ...

In severe cases, psoriasis may cause joint pain and nail ... Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. J Dermatol.

Application error: a client-side exception has occurred (see the browser console for more information).

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut' ...

Most psoriasis patients have mild or moderate forms of the disease. The former means less than 3% of the body surface area is involved, while the latter usually involves between 3% and 10%.

although Amgen is attempting to defend its product by expanding the label of the drug to include mild psoriasis. Last December, it secured FDA approval for the treatment of adult patients with ...

it extends the label for the PDE 4 inhibitor to include people with mild psoriasis, unlocking a sizeable new market for the drug, which has been approved since 2014 for moderate to severe cases.